3/27/2013 12:00:00 AM
KineMed renews diabetes collaboration with Pfizer Inc
3/13/2013 12:00:00 AM
KineMed presents Applications of Kinetic Biomarkers to Diagnose and Treat Neurological Disorders at the 2nd Neurological Biomarkers Conference
2/21/2013 12:00:00 AM
KineMed, Isis and CHDI collaborate to advance therapeutic development for Huntington’s disease and develop novel biomarkers for pre-clinical and clinical use in drug development and therapeutic monitoring
|
Dr. Marc Hellerstein, Chair of KineMed´s Scientific Advisory Board talks about the power of Proteome Dynamics at the Personalized Medicine World Conference
|